Tech
East Ventures bets on Indonesia’s PathGen to improve cancer diagnoses
[ad_1]
Founded in 2020, the biotech startup is developing next-generation sequencing for the diagnosis of cancer and other diseases.
[ad_2]
Source link
[ad_1]
Founded in 2020, the biotech startup is developing next-generation sequencing for the diagnosis of cancer and other diseases.
[ad_2]
Source link
You must be logged in to post a comment Login